Dermatologists use advanced atopic dermatitis treatments but lack predictive biomarkers for precise therapy selection.
Using insulin pump with Control-IQ technology improves glycemic status in type 2 diabetes patients with multiple daily injections, according to a study…
HIV/AIDS relief efforts disrupted, affecting vulnerable populations with HIV infection, according to PEPFAR findings and survey results.
Cancer mortality rates gap between Black and White individuals narrowed since 1990s, driven by lung and prostate cancer improvement.
Patients with eye disease face worsening conditions after losing access to copay assistance for anti-VEGF drugs, study reveals.
The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve transparency for consumers.
The U.S. Medicare drug pricing policy may cut costs by matching prices in other wealthy nations, reshaping pharmaceutical research priorities.
A new COVID-19 antibody treatment, VYD2311, enters phase 3 trials to evaluate safety and efficacy against mRNA vaccines.
Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.
New PBM regulations in 2026 enhance transparency. Learn how industry changes impact healthcare practices.